Tenet Reports Results for the Third Quarter Ended September 30, 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Tenet Healthcare (THC) Tops Q3 EPS by 23c; Lower Outlook
November 6, 2017 4:23 PM ESTTenet Healthcare (NYSE: THC) reported Q3 EPS of ($0.17), $0.23 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $4.59 billion versus the consensus estimate of $4.68 billion.
GUIDANCE:
Tenet Healthcare sees FY2017 EPS of $0.59-$0.74, versus the consensus of $0.76.
Reported a net loss from continuing operations attributable to Tenet shareholders of $366 million or $3.63 per diluted share. Adjusted diluted loss per share from continuing operations was $0.17.Adjusted EBITDA was $507 million... More